NBTX Nanobiotix S.A.

NASDAQ
$27.90

Nanobiotix S.A. (NBTX) is expected to report earnings on March 31, 2026, after the market close.

Earnings Date
3rd Quarter, Sep 2026
Mar 31
Tuesday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Nanobiotix S.A.

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.